New UK Cost-Effectiveness Thresholds Will Not Mean A Reprieve For Drugs Already Denied Reimbursement

 
• By Francesca Bruce
  
Health technology appraisals in the UK will use higher cost-effectiveness thresholds from April 2026 to help accommodate higher drug prices. (Shutterstock)

More from Pricing Debate

More from Market Access